Regional business development & portfolio expansion manager apac division - h/f

Founded in 1909, Mayoly is an independent French and international pharmaceutical company specialising in Gastroenterology and Dermo cosmetics. Following the integration of Ipsen CHC, the combined company employs more than 2,200 people worldwide and has sales of over €500 million in 2022, 65% generated internationally over 100 countries. By 2027, the Mayoly Group aims to reach sales revenue of more than €600 million and to become a global benchmark in consumer healthcare. At Mayoly, we place everyone's health first and foremost, and conduct our business in a pragmatic, responsible and caring way. We are committed to a CSR policy that also focuses on diversity and inclusion. The diversity of our employees is part of our corporate culture, One Mayoly, in which everyone can develop, grow and perform in an environment of equal opportunity. A company where every employee is a player in his/her own future and where talent can develop, always promoting collaboration and collective intelligence to meet the needs of patients, consumers, and customers. 1. External Growth the scope of opportunity sourcing is not limited to the current portfolio’s categories. 2. Geo-Expansion MBA or equivalent business qualification is a strong plus. 12-15 years of experience in Business Development, Licensing, Innovation Management, or Market Expansion in the Consumer Healthcare, Pharma, or FMCG sectors. Languages: Fluent English in written and oral, fluency in one or more Asian languages is a plus. Negotiation track record: demonstrated experience as a lead or core negotiator on licensing, partnership, or CDMO/CMO agreements, with the proven ability to carry an opportunity from initial scouting through due diligence, negotiation, and contract closure. Behavioral capacity: strong presence and gravitas; resilient and self-starting, with the ability to work autonomously and navigate ambiguity in a fast-paced, matrixed environment; able to influence and lead cross‑functional stakeholders without formal line authority; entrepreneurial mindset with cultural adaptability across diverse APAC markets. External network: an active, self-built network across the region (industry contacts, potential partners, advisors, CDMO/CMO contacts) used proactively to surface and qualify the right opportunities; deep engagement with medical KOLs is not a requirement of this role. Travel: willing and able to travel regularly across APAC markets as required by the scope of the role. Key Performance Indicators (KPIs) Number and quality of validated external growth opportunities (product dossiers, licensing, CDMO/CMO partnerships) added to the regional pipeline. Number of new market entries and/or partner agreements signed and successfully launched within agreed timelines. Conversion rate of sourced opportunities through due diligence to signed agreements, and time-to-market for new country entries and product launches versus plan. Breadth and quality of the regional BD network (industry contacts, potential partners, advisors) actively built and leveraged to generate qualified opportunities; this is the key sourcing metric for the role, and engagement with medical KOLs is not required. Quality and timeliness of business cases and due diligence packs presented to regional and global leadership / Group BD